Psychiatrists Absent from Cost-of-Care Discussions
the Psychiatry Advisor take:
Mental health services are tied with cancer as the third most expensive medical treatment in the United States, behind only heart conditions and trauma, according to researchers in JAMA Psychiatry.
Spending on psychiatric medications alone was $34 billion in 2005, surpassing expenditures on cancer drugs by $8 billion. Yet many mental health providers experience chronic underfunding for other mental health services.
Despite these issues, and growing concerns about the escalating costs of U.S. health care overall, psychiatrists remain largely absent from discussions about how to control spending.
Andres Barkil-Oteo, MD, MSc, of Yale School of Medicine, David A. Stern, MD, of New York Medical College, and Melissa R. Arbuckle, MD, PhD, of Columbia University Medical Center, discuss how front-line psychiatrists can become more involved in these efforts.
They address issues including lack of transparency about the actual cost of care, discomfort discussing treatment costs with patients and lack of incorporating cost considerations into medical training for upcoming generations of psychiatrists, as well as potential solutions to these problems.
Addressing the Cost of Health Care
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Role of Expressed Emotion in Family Psychopathology
- Serum Uric Acid May Predict Bipolar Disorder in Patients With Depression
- Group Cognitive Behavioral Therapy Is Effective Treatment for Adolescent Anxiety
- Health and Social Factors Predict Changes in Depressive Symptoms in Women
- ASD Risk on Offspring With Prenatal Use of Medication Affecting Neurotransmitter System
- Cannabis Use, Cannabis Use Disorder Linked to Psychotic, Depressive Symptoms
- Association Between Opioid and Benzodiazepine Misuse and Suicidal Ideation
- The Intersection of Eating and Alcohol Disorders: Detecting and Managing "Drunkorexia"
- Heart Rate Variability Predicts Treatment Response in Anxious Depression
- Impulsivity in Bipolar Disorder, Borderline Personality Disorder, ADHD
- Efficacy, Safety of Long-Term Ketamine Administration Still In Question
- Vulnerability to Psychosocial Disability in Psychosis
- Behavioral Health Screening Advocated for Teens With Epilepsy
- KCNQ Channel Potentiator Ezogabine Delivers Promising Results in Major Depressive Disorder
- Increase Seen in Amphetamine, Opioid Use in Pregnant Women